23
Participants
Start Date
October 31, 2008
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
artesunate
add-on therapy with daily single oral doses of 100, 150 or 200 mg of artesunate
Complementary and Integrative Medicine, Dep. Gyn. Endocrinology, Women's Hospital, University of Heidelberg, Heidelberg
Collaborators (1)
Hector-Stiftung
OTHER
Dafra Pharma
INDUSTRY
Monika-Kutzner Stiftung, Berlin, Germany
UNKNOWN
HEIFAN-Heidelberger Förderverein d. Ambulanz f. Naturheilkunde eV, Heidelberg, Germany
UNKNOWN
Heidelberg University
OTHER